Josh Resnick
Angel Investor @ RA Capital Management
Los Angeles, United States
Josh Resnick is a seed investor at RA Capital Management in Los Angeles focused on E-Commerce and Biotechnology. Josh Resnick is the Co-Founder and General Partner of Pure Imagination Brands. He is a former Co-Founder and CEO of Sugarfina. He attended Wharton School of the University of Pennsylvania.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Josh Resnick invests in
Stages Josh Resnick invests in
Countries Josh Resnick invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $655k–$60M
- Pre-Seed
- $1.4M–$1.5M
- Series A
- $1M–$75M
Investment Focus
Industry
- E-Commerce 3 (19%)
- Biotechnology 3 (19%)
- iOS 2 (13%)
- Mobile 2 (13%)
- Pharmaceutical 2 (13%)
Stage
- Seed 4 (25%)
- Series A 4 (25%)
- Pre-Seed 3 (19%)
- Series B 2 (13%)
- Series C 1 (6%)
Country
- United States 10 (63%)
- Switzerland 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties. | $90M / Series C / Jun 11, 2024 | ||
| Mariana Oncology is a biotechnology research industry. | $175M / Series B / Sep 07, 2023 | ||
Upwage
|
Our mission is to create $1 trillion in new wealth for the 44% of Americans who make less than $16/hr, using the power of big data & AI. | $2M / Convertible Note / Apr 12, 2022 | |
| Nguyen Coffee Supply is an award-winning roaster and the first specialty Vietnamese coffee company in America importing and roasting in Brooklyn, New York. Founded in 2018 by 1st generation entrepreneur-activist Sahra Nguyen, the company's mission is to increase economic advancement for Vietnamese farmers through specialty coffee production,while building a diverse and inclusive coffee culture for all. We believe Vietnamese robusta is the future of specialty coffee and sustainable farming. | $2.6M / Seed / Mar 01, 2022 | ||
| Mariana Oncology is a biotechnology research industry. | $75M / Series A / Dec 01, 2021 | ||
| Avilar Therapeutics is a bio pharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation | $60M / Seed / Nov 18, 2021 | ||
| Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties. | $107M / Series B / Jun 10, 2021 | ||
| Uprising foods are superfood keto chips and keto bread with 2 net carbs. | $1.3M / Series A / Jan 05, 2021 | ||
| Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.The company leverages insights into gasdermin biology and innate immunity to develop medicines with lead compounds that target and inhibit the pore-forming protein that mediates the release of inflammatory cytokines, alarmins, DNA and NETs, enablingpatients to get relief from inflammatory diseases. | Series A / Jan 27, 2020 | ||
| Comrad is a wellness brand that creates comfortable, functional, and supportive socks for everything you do. | $1.5M / Pre-Seed / Mar 10, 2019 | ||
| See all 16 investments → | |||
Co-Investors
About RA Capital Management
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's knowledge engine is guided by TechAtlas, its science-first internal research division. Raven, RA Capital's healthcare incubator, offers entrepreneurs and innovators a comprehensive business-building platform for biomedical innovation.
RA Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cristina Ghenoiu
Principal
|
|||
Ajay Yekkirala
VP, Head of Biology
|
|||
Andrew Levin
Managing Director
|
|||
Barbara Herbst
Deputy Chief Compliance Officer
|
|||
Dan Marks
Venture Senior Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Josh Resnick invest in?
Josh Resnick invests primarily in E-Commerce, Biotechnology and iOS startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Josh Resnick invest in?
Josh Resnick typically joins rounds of $655k–$60M at Seed, $1.4M–$1.5M at Pre-Seed and $1M–$75M at Series A. These are whole funding-round sizes, not Josh Resnick's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Josh Resnick took part in.
How do I contact Josh Resnick?
Public channels for Josh Resnick include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Josh Resnick last invest?
The most recent investment recorded for Josh Resnick closed in Jun 2024. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
